This content is machine translated Diabetes treatment Additive glucose-lowering therapy for type 1 diabetics – weighing benefits and risks Overweight type 1 diabetics in whom insulin therapy alone is not sufficient for glycemic control may receive additional oral treatment with the SGLT2 inhibitor dapagliflozin or the dual SGLT1/SGLT2 inhibitor…
